Cresco Labs (CRLBF) Cash from Investing Activities (2019 - 2026)

Cresco Labs (CRLBF) posted Cash from Investing Activities of $467000.0 for Q1 2026, up 103.53% on a QoQ basis from -$13.2 million in Q4 2025, and up 181.33% year-over-year from $166000.0 in Q1 2025.

Cresco Labs (CRLBF) Cash from Investing Activities (2019 - 2026) Analysis & Trends

Cresco Labs' Cash from Investing Activities history runs 8 years deep, the most recent figure standing at $467000.0 for Q1 2026.

  • Quarterly Cash from Investing Activities rose 181.33% year-over-year to $467000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$40.4 million (down 520.92% YoY) and the FY2025 annual result came in at -$40.7 million, down 61.34% from the prior year.
  • Cash from Investing Activities was $467000.0 for Q1 2026 at Cresco Labs, up from -$13.2 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $23.5 million in Q3 2022 and bottomed at -$21.5 million in Q2 2025.
  • A 5-year average of -$4.4 million and a median of -$6.1 million in 2025 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2025 — Cash from Investing Activities tumbled 339.5% — and 2026, when it jumped 181.33%.
  • Cresco Labs' Cash from Investing Activities stood at -$12.5 million in 2022, then jumped by 120.95% to $2.6 million in 2023, then tumbled by 215.48% to -$3.0 million in 2024, then tumbled by 339.5% to -$13.2 million in 2025, then surged by 103.53% to $467000.0 in 2026.
  • Business Quant data shows CRLBF's Cash from Investing Activities at $467000.0 in Q1 2026, -$13.2 million in Q4 2025, and -$6.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -60.00 Mn
10 Cresco Labs 245.85 Mn 182.28 Mn 75.45 Mn 467,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 467,000.00
Mar 31, 2026 467,000.00
Dec 31, 2025 -13.24 Mn
Dec 31, 2025 -13.24 Mn
Sep 30, 2025 -6.12 Mn
Sep 30, 2025 -6.12 Mn
Jun 30, 2025 -21.50 Mn
Jun 30, 2025 -21.50 Mn
Mar 31, 2025 166,000.00
Mar 31, 2025 166,000.00
Dec 31, 2024 -3.01 Mn
Dec 31, 2024 -3.01 Mn
Sep 30, 2024 -6.27 Mn
Sep 30, 2024 -6.27 Mn
Dec 31, 2023 2.61 Mn
Dec 31, 2023 2.61 Mn
Sep 30, 2023 -12.48 Mn
Sep 30, 2023 -12.48 Mn
Dec 31, 2022 -12.45 Mn
Dec 31, 2022 -12.45 Mn